← Leaderboards
Jonathan G Seidman
Harvard Medical School
$34,587,463
Attributed
$42,077,744
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$42,077,744 · 12
By mechanism
R01$20,780,352 · 4
U01$13,994,372 · 2
UM1$4,432,430 · 1
PL1$1,400,157 · 1
P50$644,028 · 1
P01$445,549 · 1
Top collaborators
- Christine E. Seidman13 shared
- Christopher S Chen8 shared
- Len Alexander Pennacchio5 shared
- William T Pu5 shared
- Axel Visel5 shared
- Sarah Morton2 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Christine E. Seidman$18,595,172
- Christopher S Chen$23,331,537
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesTissuesCardiacPathway InteractionsGene ExpressionMolecularGeneticInsightTechnologyGenetic TranscriptionHeartCellsVariantProteinsBaseGene MutationStructureMutationAdultInduced Pluripotent Stem CellData SetGrantTranscription FactorResponse
Grant awards (63)
Defining Genetic Architecture and Pathways of DCM$733,383
R01 · FY2024 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$748,350
R01 · FY2023 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$747,663
R01 · FY2022 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$535,663
R01 · FY2022 · HL · contact PI
Computational Prioritization of Coding and Non-Coding Variants in Congenital Heart Disease$175,803
R03 · FY2022 · HL
Defining Genetic Architecture and Pathways of DCM$746,700
R01 · FY2021 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$535,663
R01 · FY2021 · HL · contact PI
Computational Prioritization of Coding and Non-Coding Variants in Congenital Heart Disease$195,053
R03 · FY2021 · HL
Genetic Signals in Ventricular Hypertrophy$535,663
R01 · FY2020 · HL · contact PI
Molecular Causes of Down Syndrome Associated Congenital Heart Disease and Other Phenotypes$3,724,305
R01 · FY2019 · HL · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2019 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$665,567
R01 · FY2019 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$535,663
R01 · FY2019 · HL · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2018 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$665,567
R01 · FY2018 · HL · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2017 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$665,567
R01 · FY2017 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$423,750
R01 · FY2017 · HL · contact PI
Regulation of Cardiac Development in Health and Disease$879,536
UM1 · FY2016 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$665,567
R01 · FY2016 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$423,750
R01 · FY2016 · HL · contact PI
Regulation of Cardiac Development in Health and Disease$914,286
UM1 · FY2015 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$417,393
R01 · FY2015 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$1,855,538
U01 · FY2014 · HL · contact PI
Genetic Signals in Ventricular Hypertrophy$423,750
R01 · FY2014 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$415,275
R01 · FY2014 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$1,802,525
U01 · FY2013 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$403,410
R01 · FY2013 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$15,796
U01 · FY2013 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$1,806,962
U01 · FY2012 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$423,750
R01 · FY2012 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$1,806,962
U01 · FY2011 · HL · contact PI
Molecular Signaling in Hypertrophic Cardiomyopathy$423,750
R01 · FY2011 · HL · contact PI
Defining Genetic Architecture and Pathways of DCM$423,750
R01 · FY2011 · HL · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$254,250
PL1 · FY2011 · HL · contact PI
Mapping Transcriptional Networks in Cardiac Development$1,947,633
U01 · FY2010 · HL · contact PI
Molecular Signaling in Hypertrophic Cardiomyopathy$423,750
R01 · FY2010 · HL · contact PI
The Role of Eya4 in Hearing and Disease$339,849
R01 · FY2010 · DC · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$254,250
PL1 · FY2010 · HL · contact PI
Molecular Signaling in Hypertrophic Cardiomyopathy$423,229
R01 · FY2009 · HL · contact PI
The Role of Eya4 in Hearing and Disease$343,356
R01 · FY2009 · DC · contact PI
Mapping Transcriptional Networks in Cardiac Development$299,621
U01 · FY2009 · HL · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$254,250
PL1 · FY2009 · HL · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$30,407
PL1 · FY2009 · HL · contact PI
Defining Pathways from Gene Mutation to Heart Failure$515,536
R01 · FY2008 · HL · contact PI
Molecular Signaling in Hypertrophic Cardiomyopathy$422,500
R01 · FY2008 · HL · contact PI
The Role of Eya4 in Hearing and Disease$343,426
R01 · FY2008 · DC · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$253,500
PL1 · FY2008 · HL · contact PI
Defining Pathways from Gene Mutation to Heart Failure$512,982
R01 · FY2007 · HL · contact PI
Molecular Signaling in Hypertrophic Cardiomyopathy$423,021
R01 · FY2007 · HL · contact PI
SysCODE: PMAGE Technology Development (10 of 10)$353,500
PL1 · FY2007 · HL · contact PI
The Role of Eya4 in Hearing and Disease$352,953
R01 · FY2007 · DC · contact PI
Defining Pathways from Gene Mutation to Heart Failure$515,141
R01 · FY2006 · HL · contact PI
The Role of Eya4 in Hearing and Disease$368,166
R01 · FY2006 · DC · contact PI
Defining Pathways from Gene Mutation to Heart Failure$512,544
R01 · FY2005 · HL
GENOMICS OF CARDIOVASCULAR DEVELOPMENT, ADAPTION$963,534
U01 · FY2004 · HL
Molecular Biology of Cardiac Disease$10,000
R13 · FY2004 · HL
GENOMICS OF CARDIOVASCULAR DEVELOPMENT, ADAPTION$3,495,801
U01 · FY2003 · HL
MOLECULAR CONSEQUENCES OF SARCOMERE PROTEIN GENE MUTATIONS$214,676
P50 · FY2002 · HL
SARCOMERIC PROTEIN MUTATIONS IN HYPERTROPHY AND HEART FAILURE$220,513
P01 · FY2001 · HL
MOLECULAR CONSEQUENCES OF SARCOMERE PROTEIN GENE MUTATIONS$214,676
P50 · FY2001 · HL
SARCOMERIC PROTEIN MUTATIONS IN HYPERTROPHY AND HEART FAILURE$225,036
P01 · FY2000 · HL
MOLECULAR CONSEQUENCES OF SARCOMERE PROTEIN GENE MUTATIONS$214,676
P50 · FY2000 · HL